| |
| |
|
| Insider
Information: |
Oliviero James F Iii |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
561,014 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$608,368 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
561,014 |
|
|
| Total
Value |
$608,368 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
15
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-15.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -796.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Keryx Biopharmaceuticals Inc |
KERX |
Chief Financial Officer |
2015-07-06 |
209,406 |
2008-08-14 |
0 |
Premium* |
|
|
Checkpoint Therapeutics, Inc. |
CKPT |
CEO, President and Dir... |
2024-02-28 |
341,780 |
|
0 |
Premium* |
|
|
Nuvectis Pharma, Inc. |
NVCT |
Director |
2022-02-08 |
9,828 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVCT |
Nuvectis Pharma, Inc. |
Director |
– • – |
2022-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,828 |
|
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-27 |
4 |
S |
$4.65 |
$25,798 |
D/D |
(5,548) |
134,573 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-03-02 |
4 |
S |
$5.00 |
$27,415 |
D/D |
(5,483) |
144,090 |
0 |
% |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
149,573 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-10-03 |
4 |
S |
$16.14 |
$43,481 |
D/D |
(2,694) |
153,345 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-12-10 |
4 |
S |
$15.69 |
$392,250 |
D/D |
(25,000) |
153,345 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2014-09-08 |
4 |
S |
$15.88 |
$2,290,484 |
D/D |
(144,237) |
156,039 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-10-03 |
4 |
S |
$2.82 |
$17,192 |
D/D |
(6,105) |
161,208 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-07-05 |
4 |
S |
$4.80 |
$22,133 |
D/D |
(4,611) |
167,313 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-04-06 |
4 |
S |
$11.68 |
$21,935 |
D/D |
(1,878) |
169,738 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-01-05 |
4 |
S |
$13.79 |
$77,279 |
D/D |
(5,604) |
171,616 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-06-06 |
4 |
S |
$4.99 |
$235,683 |
D/D |
(47,231) |
171,924 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2012-04-05 |
4 |
S |
$1.60 |
$8,738 |
D/D |
(5,458) |
176,560 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
23,875 |
177,220 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2012-01-03 |
4 |
S |
$2.63 |
$18,874 |
D/D |
(7,190) |
182,018 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-02-01 |
4 |
S |
$4.77 |
$48,945 |
D/D |
(10,261) |
182,121 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2012-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
28,000 |
189,208 |
0 |
- |
|
| CKPT |
Checkpoint Therapeutics, ... |
CEO, President and Director |
• • – |
2023-01-10 |
4 |
S |
$6.75 |
$25,761 |
D/D |
(3,817) |
192,382 |
0 |
% |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-07-06 |
4 |
S |
$9.61 |
$18,672 |
D/D |
(1,943) |
209,406 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2015-05-12 |
4 |
OE |
$2.53 |
$111,095 |
D/D |
41,611 |
211,349 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-04-05 |
4 |
S |
$5.10 |
$22,899 |
D/D |
(4,490) |
219,155 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-12-06 |
4 |
S |
$5.00 |
$18,000 |
D/D |
(3,600) |
221,459 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-01-03 |
4 |
S |
$4.67 |
$65,679 |
D/D |
(14,064) |
223,645 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2010-12-03 |
4 |
S |
$5.06 |
$122,199 |
D/D |
(24,150) |
225,059 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Chief Financial Officer |
• – – |
2011-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
16,250 |
237,709 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
